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Chemical examination of two marine Streptomycetes has resulted in the isolation of four new butenolides,
namely 4,10-dihydroxy-10-methyl-dodec-2-en-1,4-olide (1), two diastereomeric 4,11-dihydroxy-10-methyl-
dodec-2-en-1,4-olides (2/3), and 4-hydroxy-10-methyl-11-oxo-dodec-2-en-1,4-olide (4). The structures were
identified by interpretation of the 2D NMR and mass spectral data.
Butenolides, a family of R,â-unsaturated lactones, are
often encountered among fungi,2 bacteria,3 and gorgonians,4
to name a few. Their saturated analogues act as signaling
substances in bacteria5 and enhance spore formation of
Streptomycetes or induce metabolite production.6 In a
continuing search for bioactive constituents from marine
microorganisms, we found that extracts from the Strepto-
mycete strains B 5632 and B 3497 from marine sediments
formed several new butenolides.
The isolate B 5632 was fermented in a 20-L scale on
YMG medium with artificial seawater for 3 days. The
fermentation broth was filtered over Celite and exhaus-
tively extracted with ethyl acetate. This extract was
partitioned between methanol and cyclohexane for defat-
ting, and the methanol layer, after concentration, was
chromatographed on a flash column. Bioassay-guided
fractionation led to the localization of the activity from
which four known antimycins and three new butenolides
(1-3) were obtained. In a similar way, strain B 3497
delivered a new keto butenolide (4) in addition to antimycin
A. The antimycins were responsible for the strong anti-
fungal activity of the extracts against Mucor miehei
(Tu¨284).
Analytical HPLC indicated that the butenolide fraction
(localized by a strong blue-violet color on spraying with
anisaldehyde) contained two related compounds. Com-
pound 1 was obtained as an oil by preparative HPLC.
Under EIMS conditions, no molecular ion was visible;
however, its molecular mass was fixed as 226 Da by
pseudomolecular ions at m/z 244 [M+ + NH4] and 226 [M+
+ NH4 - H2O] on CIMS. An APT spectrum showed that
the compound contained two methyl, six methylene, three
methine, and two quaternary carbons, according to a
formula C13H22O3, in agreement with chemical shifts. The
proton signals at ä 7.44 and 6.11 and a carbon signal at ä
173.2 indicated that the compound had an R,â-unsaturated
lactone, ester, or acid moiety. The molecular formula
demands three double-bond equivalents. As two are ac-
counted for by an ester or lactone carbonyl and a double
bond, the molecule must be monocyclic. The H-H COSY
spectrum showed couplings between the two olefinic pro-
tons and a multiplet at ä 5.01, indicating an oxygenated
carbon next to the double bond. This methine showed
further coupling to two methylene protons, which, in turn,
were coupled to another methylene group. An HMQC
spectrum correlated the proton signal at ä 5.01 to a
methine signal at ä 83.4. This sequence resulted in frag-
ment a.
Additionally, the 1H NMR spectrum showed a clear
quartet and a triplet, indicating the presence of an isolated
ethyl group in the molecule. A signal for an isolated methyl
group and the HMBC correlations showed that the mol-
ecule must contain fragment b. Because the molecule
contains one ring as discussed above, the open ends of the
partial structures a and b need to be closed while incor-
porating three methylene units.
Three structures are in accordance with these data, the
butenolide 1 and two macrocyclic lactones. The negligible
H-H coupling of the R- and â-protons with the adjacent
methine proton indicated a nearly 90° orientation and a
flat system; a strained ring is also consistent with the small
cis coupling constant and the IRCO signal at î ) 1750 cm-1.
The shift values and the carbonyl frequency are in very
good agreement with data reported for maritolide (5) from
Diospyros maritima7 (13C NMR data, see Table 1; îCO )
1755 cm-1) and related compounds. Although, no HMBC
coupling of 4-H with the carbonyl group or between ring
and chain is visible, as in 5, there is no doubt that this
compound is 4,10-dihydroxy-10-methyl-dodec-2-en-1,4-olide
(1).
The absolute configuration at C-4 has been fixed by CD
measurements and comparison with a butenolide (6) of
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known absolute stereochemistry.8 As butenolide 1 shows
a negative n-ð* and a positive ð - ð* Cotton effect, the
configuration at C-4 must be S, as in 6.
The doubling of signals in the 13C and the 1H NMR
spectra indicated that the oily fraction 2 was a mixture of
two related compounds in a ratio close to 1:1. They did not
deliver an M+ ion in the EIMS, but showed the same mass
in the CI spectrum and gave a butenolide carbonyl signal
at î ) 1758 cm-1 and a similar NMR pattern as 1.
However, the terminal ethyl signal was substituted by two
overlapping CH-CH3 doublets, and two additional methine
signals indicated that oxygen in 1 had shifted from C-10
to C-11, resulting in the diastereomeric structures 2 and
3. The CD spectrum with a positive ð - ð* transition at
208 nm indicated a 4S configuration.
Compound 4 was obtained from another Streptomycete
strain B 3497. Its molecular formula was fixed as C13H20O3
by the pseudomolecular ion at m/z 242 [M+ + NH4] in its
CIMS and the NMR data. The 1H NMR pattern was very
similar to those of compounds 1-3, and the presence of an
extra carbonyl absorption at 1708 cm-1 in addition to the
R,â-unsaturated lactone carbonyl absorption (1754 cm-1)
suggested that compound 4 contains a ketone carbonyl. The
presence of a methyl ketone singlet and the absence of a
terminal methyl triplet in the proton NMR spectrum
indicated structure 4, which was finally confirmed by COSY
and HMQC spectra similarly as for 1. Due to the positive
ð - ð* Cotton effect, the configuration at C-4 must be the
same as in 1 and 2/3.
The presence of two positional isomers 1 and 2/3 suggests
an epoxide precursor in their biosynthesis, as it also may
be involved in the biosynthesis of the phytotoxins seiridin,
isoseiridin,9 hydroxyseiridin, hydroxyisoseiridin,10 and iso-
cladospolide B.2 Corresponding epoxides have not yet been
reported; however, the epoxyrollins11 A and B with epoxides
in C-2 side chains are related structures.
Despite spore formation-promoting activity, some other
butenolides3 are active against Pseudomonas aeruginosa
and inhibit the chitinase from Serratia marcescens. Com-
pound 4 did not show activity against Escherichia coli,
Staphylococcus aureus, Candida albicans, Mucor miehei
(Tu¨284), or Streptomyces viridochromogenes (Tu¨57), and
1-4 showed no influence on spore formation of S. virido-
chromogenes (Tu¨57) or of some marine Streptomycetes.
Experimental Section
General Experimental Procedures. The CD spectra and
optical rotations were run on a JASCO J-500 Aa spectropola-
rimeter. NMR spectra were measured on a Varian Unity 300
(300.145 MHz) and a Varian Inova 500 (499.876 MHz)
spectrometer in CDCl3 with TMS as internal standard. CIMS
was recorded on a Finnigan MAT 95 A instrument using NH3.
Preparative HPLC was performed using a RP18 column with
a diode array detector. Flash chromatography was carried out
on Si gel (230-400 mesh).
Strain Description. The Actinomycete stain B3497 was
collected from a North Atlantic Ocean sediment (58°19′N,
14°57′W at 680 m depth) and isolated on a casein/peptone
medium (50% seawater) at 18 °C.12 The strain B5632 has been
derived from muddy sediment of a mangrove site near Auck-
land, New Zealand, and was isolated on Olson medium
containing 22 g of actinomycete isolation agar (Difco) and 5 g
of glycerol in 1 L of 50% natural seawater. The reference
cultures of B5632 are kept on yeast extract-malt extract
agar12 in the collection of marine Actinomycetes at the Alfred-
Wegener-Institute for Polar and Marine Research in Bremer-
haven. According to the partial 16S rRNA gene sequence, the
strains B5632 and B3497 are representatives of the Strepto-
myces coelicolor group.
The strains produce a yellow-brown substrate mycelium and
a yellow aerial mycelium with straight to flexuous (rectiflexi-
biles) spore chains. The surface of the spores is smooth. The
strains do not produce melanin on either peptone/yeast extract/
iron agar or on tyrosine agar.13
The optimum temperature for strain growth is 30 °C. The
strains grow slowly at 10 °C but show no growth at 45 °C.
Chitin, starch, casein, gelatine, and esculin are degraded.
Cellulose is not cleaved. The strains are catalase positive. Only
strain B5632 forms nitrate reductase. The strains deviate
further in the use of the following carbon sources (SFN-Biolog
plates): turanose, D-glucosaminic acid, R-keto butyric acid,
R-keto valeric acid, propionic acid, L-leucine, L-threonine,
2-aminoethanol with positive growth response for B5632 and
acetic acid, bromosuccinic acid, L-histidine, thymidine with
positive growth results for B3497.
Fermentation. Fermentation was performed using stan-
dard conditions1 on YMG medium with artificial seawater. The
bacterial cultures B 5632 and B 3497 were grown on agar
plates at 28 °C for 3 days and then transferred to shaker
cultures (15  200 mL). These seed cultures were used to
inoculate the fermenter, which was harvested after 3 days.
Extraction and Isolation. Fermentation broth of B 5632
was filtered through a press filter using Celite, and the filtrate
and bacterial cells were extracted with ethyl acetate. The
combined ethyl acetate extracts were concentrated in vacuo
at 37 °C and the residue (1.5 g) partitioned between methanol
and cyclohexane. The defatted methanol layer (0.8 g) was
concentrated and loaded on a flash column (30  600 mm),
which was eluted with chloroform and a stepwise increasing
gradient of methanol. The residue from the chloroform-
methanol (8:2) fraction (50 mg) gave, respectively, yellow and
blue-violet spots on spraying with anisaldehyde/sulfuric acid
and was further purified on a Sephadex LH-20 column eluting
with chloroform-methanol (6:4) into two main fractions. The
first fraction (20 mg) was rich in antimycins (Rf ) 0.43,
CHCl3-MeOH, 95:5, yellow with anisaldehyde), while the
second (15 mg) contained butenolides. HPLC and MS analysis
showed that the antimycin mixture contained only known
compounds. Preparative HPLC (C18, Eurosphere, 80A/5 ím,
16  250 mm, CH3CN-H2O, 1:1) of the butenolide fraction
resulted in the isolation of pure compound 1 (2 mg) and a
mixture of 2 and 3 (2 mg). In the same way, cultivation and
workup of a 20-L culture from B 3497 gave 12 mg of antimycin
A (Rf ) 0.43, CHCl3-MeOH, 95:5) and 4 mg of 4.
(4S)-4,10-Dihydroxy-10-methyl-dodec-2-en-1,4-olide (1):
Rf 0.53 (CHCl3-MeOH 95:5), blue-violet with anisaldehyde-
Table 1. 13C NMR Data for Butenolides 1-5 in CDCl3
atom 1 2 3 4 5a
1 CO 173.2 173.2 173.2 173.0 173.8
2 CH 121.6 121.6 121.6 121.4 121.6
3 CH 156.2 156.3 156.3 156.2 156.2
4 CH 83.4 83.4 83.4 83.2 83.4
5 CH2 33.1 32.4 33.2 32.9 33.2
6 CH2 25.0 25.0 25.0 24.7
7 CH2 29.9 29.6 29.7 29.2
8 CH2 23.6 27.0 27.1 26.8
9 CH2 41.1 32.4 32.4 32.5
10 72.9 Cq 39.6 CH 40.0 CH 47.0 CH
11 34.3 CH2 71.3 CH 71.7 CH 212.6 CO
12 CH3 8.2 19.5 20.3 27.9
13 CH3 26.4 14.2 14.6 16.1
a Only relevant values are listed.
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sulfuric acid; UV (MeOH) ìmax (log ) 207 (3.63) nm; [R]22D +44°
(c 0.072, CH3OH); CD [ı]205 (MeOH) +24 800; IR (KBr) îmax
3436, 2928, 2856, 1750, 1568, 1459, 1379, 1166, 1103, 819
cm-1; 1H NMR (500 MHz, CDCl3) ä 7.44 (1 H, dd, J ) 5.6, 1.5
Hz, H-3), 6.11 (1 H, dd, J ) 6.1, 2.3 Hz, H-2), 5.01 (1 H, dddd,
J ) 7.5, 5.3, 1.9, 1.9 Hz, H-4), 1.78 (1 H, m, H-5a), 1.62 (1 H,
m, H-5b), 1.42 (2 H, q, J ) 7. 3 Hz, H2-11), 1.40 (m), 1.32 (m),
1.22 (m), 1.12 (3 H, s, CH3-13), 0.84 (3 H, t, J ) 7.6 Hz, CH3-
12); 13C NMR, see Table 1; CIMS m/z 244 [M + NH4]+ and
226 [M + NH4 - H2O]+.
(4S)-4,11-Dihydroxy-10-methyl-dodec-2-en-1,4-olides (2/
3): inseparable mixture of two diastereomers, Rf 0.53 (CHCl3-
MeOH 95:5), blue-violet with anisaldehyde-sulfuric acid; UV
(MeCN) ìmax (log ) 200 (3.80) nm; [R]22D +84.5° (c 0.119, CH3-
OH); CD [ı]208 (MeOH) +23 700; IR (KBr) îmax 2949, 2882,
1758, 1475, 1400, 1182, 1121, 838 cm-1; 1H NMR (300 MHz,
CDCl3) ä 7.44 (1 H, dd, J ) 5.7, 1.5, H-3), 6.11 (1 H, dd, J )
5.7, 1.9, H-2), 5.03 (1 H, m, H-4), 3.72, 3.65 (each 1 H, m, H-11
of 2 and 3), 1.92-1.25 (11 H, m), 1.14, 1.16 (each 3 H, 2 d, J
) 6.4, CH3-12 of 2 and 3), 0.88, 0.86 (each 3 H, 2 d, J ) 6.8,
CH3-13 of 2 and 3); 13C NMR, see Table 1; CIMS m/z 244 [M
+ NH4]+ and 226 [M + NH4 - H2O]+.
(4S)-4-Hydroxy-10-methyl-11-oxo-dodec-2-en-1,4-
olide (4): Rf 0.37 (CHCl3-MeOH 95:5), violet with anisalde-
hyde-sulfuric acid; UV (MeCN) ìmax (log ) 200 (4.13), 250
(3.47) nm; [R]22D +45° (c 0.119, CH3OH); CD [ı]204 (MeCN)
+25 400; IR (film) îmax 2935, 2860, 1754, 1708, 1600 cm-1; 1H
NMR (CDCl3, 300 MHz) ä 7.44 (1 H, dd, J ) 5.9, 1.5 Hz, H-3),
6.12 (1 H, dd, J ) 5.9, 2.0 Hz, H-2), 5.04 (1 H, m, H-4), 2.50 (1
H, m, J ) 5 Hz, H-10), 2.12 (3 H, s, CH3-12), 1.70 (1 H, m),
1.60 (2 H, m), 1.40 (2H, m), 1.35-1.15 (5 H, m), 1.09 (3 H, d,
J ) 7 Hz, CH3-13); 13C NMR, see Table 1; EIMS m/z 224 [M]+
(14), 182 (20), 153 (100); DCIMS m/z 242 [M + NH4]+ (100),
225 [M + H]+ (0.01); anal. C 69.66%, H 9.07%, calcd for
C13H20O3, C 69.61%, H 8.99%.
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